1. Farahani N, Braun A, Jutt D, Huffman T, Reder N, Liu Z, et al. Three-dimensional Imaging and Scanning: Current and Future Applications for Pathology. J Pathol Inform. 2017;8: 36.
2. Farahani N, Liu Z, Jutt D, Fine JL. Pathologists’ Computer-Assisted Diagnosis: A Mock-up of a Prototype Information System to Facilitate Automation of Pathology Sign-out. Arch Pathol Lab Med. 2017;141: 1413–1420.
3. Sokolovskaya E, Liu Z, Weintraub K, Szallasi A, Shariff Y. Case Report: Primary Leiomyosarcoma of the breast with unusual metastasis to the femur. F1000Res. 2014; doi:10.12688/f1000research.5213.1
4. Liu Z, Davidson A. IFNα Inducible Models of Murine SLE. Front Immunol. 2013;4: 306.
5. Liu Z, Bethunaickan R, Sahu R, Brenner M, Laragione T, Gulko PS, Davidson A. The Multiple Chemokine-Binding Bovine Herpesvirus 1 Glycoprotein G (BHV1gG) Inhibits Polymorphonuclear Cell but Not Monocyte Migration into Inflammatory Sites. Mol Med. 2013; 19(1):276-285.
6. Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med. 2012;18: 871–882.
7. Bethunaickan R, Sahu R, Liu Z, Tang YT, Huang W, Edegbe O, et al. Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. Arthritis & Rheumatism. 2012;64: 3399–3408.
8. Liu Z, Davidson A. BAFF and selection of autoreactive B cells. Trends Immunol. 2011;32: 388–394.
9. Liu Z, Bethunaickan R, Huang W, Ramanujam M, Madaio MP, Davidson A. IFN- Confers Resistance of Systemic Lupus Erythematosus Nephritis to Therapy in NZB/W F1 Mice. The Journal of Immunology. 2011;187: 1506–1513.
10. Liu Z, Davidson A. BAFF inhibition: a new class of drugs for the treatment of autoimmunity. Exp Cell Res. 2011;317: 1270–1277.
11. Liu Z, Zou Y, Davidson A. Plasma cells in systemic lupus erythematosus: the long and short of it all. Eur J Immunol. 2011;41: 588–591.
12. Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, et al. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner. Arthritis Rheum. 2011;63: 219–229.
13. Liu Z, Davidson A. Inhibitory short synthetic oligodeoxynucleotides and lupus. Arthritis Res Ther. 2009;11: 116.
14. Ramanujam M, Wang X, Huang W, Liu Z, Schiffer L, Tao H, et al. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest. 2006;116: 724–734.